A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model

類似資料

• Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
  著者:: Tolcher, Anthony W., 等
  出版事項: (2008)
• Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer
  著者:: Xu, Peng, 等
  出版事項: (2016)
• The Mechanism of Radiosensitization by YM155, a Novel Small Molecule Inhibitor of Survivin Expression, is Associated with DNA Damage Repair
  著者:: Songliu Hu, 等
  出版事項: (2015-09-01)
• The survivin suppressant YM155 reverses doxorubicin resistance in osteosarcoma
  著者:: Zhang, Zhuo, 等
  出版事項: (2015)
• TAT-IL-24-KDEL-induced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor, YM155, in cancer cells
  著者:: Zhang, Jian, 等
  出版事項: (2016)